BNR
Burning Rock Biotech Ltd
Stock NASDAQ – Stock Market Prices, News & Analysis
Chinese biotechnology company specializing in molecular cancer diagnostics and genomic testing for personalized oncology medicine.
Burning Rock Biotech Ltd
BNR
Chinese biotechnology company specializing in molecular cancer diagnostics and genomic testing for personalized oncology medicine.
Price history of Burning Rock Biotech Ltd
Price history of Burning Rock Biotech Ltd
Performance & Momentum
Strategic Analysis
Burning Rock Biotech Ltd • 2026
Burning Rock Biotech positions itself as a key player in molecular diagnostics in oncology in China, offering advanced genomic testing for personalized medicine. Its model relies on the integration of sophisticated biotechnological technologies to improve diagnostic precision and targeted cancer treatment.
- Strong specialization in molecular diagnostics and personalized medicine applied to oncology
- Presence in the Chinese market, one of the most dynamic in biotechnology and healthcare
- Large portfolio of genomic tests supporting clinical innovation
- Significant volatility of long-term performance
- Exposure to regulatory and market risks specific to the Chinese biotechnology sector
The momentum shows a significant recovery after heavy declines over three and five years, indicating a resurgence of investor interest and a possible consolidation of its model. This positive momentum deserves to be monitored in the context of a sector undergoing rapid technological and regulatory evolution.
Similar stocks to Burning Rock Biotech Ltd
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
